Literature DB >> 29617859

Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis.

Stefania Marsico1, Francesca Caccuri2, Pietro Mazzuca2, Paola Apostoli2, Sara Roversi2, Giovanni Lorenzin2, Alberto Zani2, Simona Fiorentini2, Cinzia Giagulli2, Arnaldo Caruso2.   

Abstract

Human metapneumovirus (hMPV) has been identified as a major cause of lower respiratory tract infection in children. Epidemiological and molecular evidence has highlighted an association between severe childhood respiratory viral infection and chronic lung diseases, such as asthma and chronic obstructive pulmonary disease. Currently, animal models have demonstrated the ability of hMPV to persist in vivo suggesting a role of the virus in asthma development in children. However, mechanisms involved in hMPV persistence in the respiratory tract are not yet understood. In the present study we monitored hMPV infection in human alveolar epithelial A549 cells in order to understand if the virus is able to persist in these cells upon acute infection. Our data show that hMPV initially induces an apoptotic process in A549 cells through poly (ADP-ribose) polymerase 1 cleavage, caspase-3/7 activation and Wee1 activity. The hMPV-infected cells were then able to overcome the apoptotic pathway and cell cycle arrest in G2/M by expressing B-cell lymphoma 2 and to acquire a reservoir cell phenotype with constant production of infectious virus. These findings provide evidence of the ability of hMPV to persist in alveolar epithelial cells and help in understanding the mechanisms responsible for hMPV persistence in the human respiratory tract.

Entities:  

Mesh:

Year:  2018        PMID: 29617859     DOI: 10.1093/femspd/fty013

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  6 in total

1.  Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.

Authors:  J Tyler Kinder; Carole L Moncman; Chelsea Barrett; Hong Jin; Nicole Kallewaard; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

Review 2.  Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System.

Authors:  Jorge A Soto; Nicolás M S Gálvez; Felipe M Benavente; Magdalena S Pizarro-Ortega; Margarita K Lay; Claudia Riedel; Susan M Bueno; Pablo A Gonzalez; Alexis M Kalergis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

Review 3.  Cell-Mediated Responses to Human Metapneumovirus Infection.

Authors:  Marlies Ballegeer; Xavier Saelens
Journal:  Viruses       Date:  2020-05-14       Impact factor: 5.048

Review 4.  Are Community Acquired Respiratory Viral Infections an Underestimated Burden in Hematology Patients?

Authors:  Cristian-Marian Popescu; Aurora Livia Ursache; Gavriela Feketea; Corina Bocsan; Laura Jimbu; Oana Mesaros; Michael Edwards; Hongwei Wang; Iulia Berceanu; Alexandra Neaga; Mihnea Zdrenghea
Journal:  Microorganisms       Date:  2019-11-02

5.  Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice.

Authors:  Jorge A Soto; Nicolás M S Gálvez; Gaspar A Pacheco; Gisela Canedo-Marroquín; Susan M Bueno; Alexis M Kalergis
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

Review 6.  Mechanisms of Virus-Induced Airway Immunity Dysfunction in the Pathogenesis of COPD Disease, Progression, and Exacerbation.

Authors:  Hong Guo-Parke; Dermot Linden; Sinéad Weldon; Joseph C Kidney; Clifford C Taggart
Journal:  Front Immunol       Date:  2020-06-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.